Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Imfinzi
Imfinzi
AstraZeneca’s Imfinzi tackles another type of lung cancer with latest trial win
Fierce Pharma
Fri, 04/5/24 - 11:28 am
AstraZeneca
Imfinzi
clinical trials
limited-stage small cell lung cancer
AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need
BioSpace
Mon, 03/18/24 - 05:19 pm
AstraZeneca
Lynparza
Imfinzi
endometrial cancer
AstraZeneca reports positive data from Phase III trial of Imfinzi
Clinical Trials Arena
Mon, 01/22/24 - 11:29 am
AstraZeneca
Imfinzi
clinical trials
hepatocellular carcinoma
AstraZeneca charts new course for Imfinzi in liver cancer, but FDA path remains uncertain
Fierce Pharma
Fri, 01/19/24 - 11:13 am
AstraZenca
liver cancer
Imfinzi
AstraZeneca’s Imfinzi Phase III trial raises trial design questions
Clinical Trials Arena
Tue, 11/21/23 - 11:41 am
AstraZeneca
Imfinzi
clinical trials
AstraZeneca Bid to Expand Imfinzi’s NSCLC Label Hit with Phase III Flop
BioSpace
Tue, 11/14/23 - 10:55 am
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
AstraZeneca’s Imfinzi meets PFS primary endpoint in Phase III HCC trial
Clinical Trials Arena
Fri, 11/10/23 - 10:06 am
AstraZeneca
clinical trials
Imfinzi
hepatocellular carcinoma
Merck's Keytruda nabs FDA nod in biliary tract cancer, catching up with AstraZeneca's Imfinzi
Fierce Pharma
Wed, 11/1/23 - 10:10 pm
Merck
AstraZeneca
biliary tract cancer
Keytruda
Imfinzi
AstraZeneca’s liver cancer treatment shows ‘continued survival benefit’ in phase 3 trial
Biopharma Reporter
Mon, 07/3/23 - 10:46 am
AstraZeneca
Imfinzi
liver cancer
clinical trials
ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?
Fierce Pharma
Sun, 06/4/23 - 04:24 pm
ASCO 2023
AstraZeneca
Lynparza
Imfinzi
ovarian cancer
AstraZeneca reports positive results from endometrial cancer therapy trial
Clinical Trials Arena
Mon, 05/29/23 - 12:24 pm
AstraZeneca
endometrial cancer
clinical trials
Imfinzi
Lynparza
AstraZeneca's drug combo shows positive results in late-stage cancer trial
Reuters
Fri, 05/26/23 - 10:09 am
ASCO 2023
AstraZeneca
Imfinzi
Lynparza
endometrial cancer
AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate
Fierce Pharma
Sun, 04/16/23 - 11:22 pm
AstraZeneca
AACR
Imfinzi
non-small cell lung cancer
AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer
Endpoints
Wed, 04/5/23 - 10:14 am
AstraZeneca
Lynparza
Imfinzi
ovarian cancer
clinical trials
AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial
Reuters
Thu, 03/9/23 - 11:40 am
AstraZeneca
Imfinzi
lung cancer
Despite Imfinzi fail in lung cancer trial, AZ 'encouraged' by one result: exec
Fierce Pharma
Mon, 12/19/22 - 12:29 pm
AstraZeneca
Imfinzi
lung cancer
non-small cell lung cancer
AstraZeneca: FDA Approves Imfinzi Plus Chemotherapy To Treat Biliary Tract Cancer
NASDAQ
Tue, 09/6/22 - 05:04 pm
AstraZeneca
Imfinzi
biliary tract cancer
FDA
AstraZeneca, chasing immunotherapy rivals, claims study success in early lung cancer
BioPharma Dive
Thu, 06/30/22 - 11:01 am
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
Here's What AstraZeneca's Recent FDA News Means for Shareholders
Motley Fool
Mon, 05/30/22 - 10:15 am
AstraZeneca
FDA
Imfinzi
tremelimumab
liver cancer
AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer
Pharmaforum
Thu, 05/5/22 - 10:38 am
AstraZeneca
Imfinzi
biliary tract cancer
FDA
priority review
Pages
1
2
3
4
next ›
last »